Oric Pharmaceuticals Inc (ORIC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $13.50
• Market Cap: $1.31B
• EPS: $-1.71
• 52-Week High: $14.93
• 52-Week Low: $3.90

Market Sentiment

Oric Pharmaceuticals Inc currently has a Bullish sentiment score of 0.28.

About Oric Pharmaceuticals Inc

Oric Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to the discovery and development of innovative cancer therapies. Utilizing its proprietary drug development platforms, Oric targets significant unmet medical needs in oncology, particularly concerning resistance to existing treatments. The company's promising pipeline, which includes candidates designed to inhibit specific mechanisms of cancer cell survival, pos...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Oric Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ORIC pay dividends?

Oric Pharmaceuticals Inc (ORIC) does not currently pay a regular dividend.

What is ORIC's market cap?

Oric Pharmaceuticals Inc (ORIC) has a market capitalization of $1.31B with a current stock price of $13.50.